TXMD - TherapeuticsMD, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts6688
Avg. Estimate-0.18-0.18-0.74-0.43
Low Estimate-0.21-0.25-0.79-0.63
High Estimate-0.17-0.12-0.68-0.25
Year Ago EPS-0.16-0.17-0.59-0.74
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts7788
Avg. Estimate8.6M14.15M31.58M129.88M
Low Estimate7.3M10.7M30.42M85.18M
High Estimate11.8M17.6M33.09M187.99M
Year Ago SalesN/A5.09M16.1M31.58M
Sales Growth (year/est)N/A178.00%96.20%311.30%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.21-0.17-0.17-0.17
EPS Actual-0.16-0.17-0.16-0.23
Difference0.0500.01-0.06
Surprise %23.80%0.00%5.90%-35.30%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.18-0.18-0.74-0.43
7 Days Ago-0.19-0.18-0.74-0.43
30 Days Ago-0.19-0.18-0.74-0.37
60 Days Ago-0.18-0.17-0.69-0.31
90 Days Ago-0.18-0.17-0.69-0.25
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days11N/AN/A
Up Last 30 Days11N/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesTXMDIndustrySectorS&P 500
Current Qtr.-12.50%N/AN/A-0.00
Next Qtr.-5.90%N/AN/A0.08
Current Year-25.40%N/AN/A-0.01
Next Year41.90%N/AN/A0.14
Next 5 Years (per annum)19.50%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A